Objective To investigate the clinical effect of azithromycin and Xiyanping in the treatment of mycoplasma pneumonia in children. Methods Two hundred and fifty children with mycoplasma pneumonia were treated in our hospital from July 2016 to July 2018. They were treated with azithromycin and hippophine as observation group, and 250 children with mycoplasma pneumonia were treated with azithromycin as control group. The clinical conditions of the two groups were compared during the treatment, and the therapeutic effect, disappearance time of symptoms and signs and adverse reactions were compared between the two groups. Results The total effective rate showed that the observation group was higher than the control group, the difference was significant (P＜0.05), with statistical significance. The disappearance time of symptoms and signs showed that the observation group was shorter than the control group, the difference was significant (P＜0.05), with statistical significance. The incidence of adverse reactions showed that the observation group was lower than the control group, the difference was significant (P＜0.05), with statistical significance. Conclusion Azithromycin combined with Xiyanping can effectively improve the symptoms of children with mycoplasma pneumonia and has high safety.%目的 对阿奇霉素、喜炎平联合治疗小儿支原体肺炎的临床效果进行探讨.方法 以250例小儿支原体肺炎患者作为此次研究的对象人群,均于2016年7月份到2018年7月份于我院进行诊治,并将其设为观察组,予以阿奇霉素联合喜炎平治疗;同期纳入250例小儿支原体肺炎患者设为对照组,予以阿奇霉素治疗.比较两组患者在此次治疗过程中的临床情况,并比较两组患者的治疗效果、症状体征消失时间以及不良反应.结果 总有效率显示,观察组高于对照组,差异显著(P＜0.05),有统计学意义.症状体征消失时间显示,观察组短于对照组,差异显著(P＜0.05),有统计学意义.不良反应发生率显示,观察组低于对照组,差异显著(P＜0.05),有统计学意义.结论 对小儿支原体肺炎患者实施阿奇霉素联合喜炎平治疗,能够有效改善患者病情症状,安全性高.
展开▼
